DeutschNewstral
Article
Mmarketwatch.com on 2017-04-20 15:09
Immune Pharma's stock rockets on heavy volume after license pact
Related news
AI: Pharma's Perfect MedicineForbes- MGW Pharma's marijuana-derived epilepsy drug sales continue to climbmarketwatch.com
- TImmune Defence Reviewtheguardianonline.com
- MIMedia's stock rockets on heavy volume after Shaq partnershipmarketwatch.com
- MIBio's stock rockets on heavy volume after Russell index inclusionmarketwatch.com
- MIntegrated Media Technology shares rockets over 1,000% on heavy volumemarketwatch.com
- MNeothetics's stock rockets on heavy volume after merger dealmarketwatch.com
- MDigital Power's stock rockets on heavy volume as bitcoin soarsmarketwatch.com
- MTransEnterix's stock rockets to 18-month high on heavy volumemarketwatch.com
The Privacist - Volume 2jdsupra.com- Blockchain Energizer – Volume 28jdsupra.com
- The Energizer – Volume 80jdsupra.com
Roku Signs TiVo License Pact Covering 6,000 Patentsvariety.com
Immune to populism? - Saviour Rizzotimesofmalta.com- FBig Pharma's Pollution Is Creating Deadly Superbugs While the World Looks the Other Wayfeeds.feedblitz.com
- MMarin Software's stock rockets 60% on Google revenue pactmarketwatch.com
Vaccine blood-clot side effect puts focus on immune reactionThe Japan Times- Brazil’s Globo, Spain’s Atresmedia Renew Pactvariety.com
Pharma's Market
Another reason to visit Egypt: Europe’s high drug pricesPolitico.eu- MInnate Pharma's stock rallies 23% on leukemia drug submission in Europemarketwatch.com